Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Nashville,, Tennessee
- Most recent report
- 8-K/A, filed Sep 11, 2026
- Incorporated
- Tennessee
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1087294
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 70
News 8 of 231
- 8-K/A Shareholder vote results Sep 11, 2026
- 8-K Current report on a material event Aug 28, 2026
- 8-K Quarterly results Aug 4, 2026
- 8-K Other events Jul 13, 2026
- 8-K Leadership change Jul 1, 2026
- 8-K Shareholder vote results Jun 25, 2026
- 8-K Quarterly results May 5, 2026
- 8-K Shareholder vote results Apr 24, 2026
Prospectuses and Registrations 8 of 19
- 424B5 Prospectus supplement for an offering Feb 14, 2025
- 424B5 Prospectus supplement for an offering Mar 20, 2024
- S-3 Shelf registration statement Dec 14, 2023
- S-8 Registration statement for an employee plan May 16, 2023
- 424B5 Prospectus supplement for an offering Dec 27, 2021
- S-3 Shelf registration statement Dec 11, 2020
- S-3/A Shelf registration statement, amended Jan 9, 2018
- S-3/A Shelf registration statement, amended Dec 19, 2017
Proxies 8 of 28
- DEFM14A May 26, 2026
- PREM14A May 15, 2026
- DEFA14A Extra proxy material Apr 23, 2026
- DEFA14A Extra proxy material Mar 9, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 9, 2026
- DEFA14A Extra proxy material Mar 10, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 10, 2025
- DEFA14A Extra proxy material Mar 13, 2024
Ownership 8 of 573
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
Other 8 of 79
- ARS Annual report sent to shareholders Mar 12, 2026
- UPLOAD Comment letter from SEC staff Aug 25, 2025
- CORRESP Reply to SEC staff Aug 15, 2025
- UPLOAD Comment letter from SEC staff Aug 4, 2025
- ARS Annual report sent to shareholders Mar 18, 2025
- ARS Annual report sent to shareholders Mar 22, 2024
- EFFECT Notice that a registration became effective Dec 26, 2023
- CORRESP Reply to SEC staff Dec 21, 2023
Everything here comes from Cumberland Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.